Cited by 713Hormonal and reproductive studiesProstate Cancer Treatment and ResearchMenopause: Health Impacts and Treatments

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Risks of testosterone-replacement therapy and recommendations for monitoring.

Rhoden, Ernani Luis, Morgentaler, Abraham·2004·New England Journal of Medicine

DOI 10.1056/nejmra022251

Open this paper in CoChat — free account

Abstract

Although some reports suggest that testosterone-replacement therapy may provide benefits for aging men, considerable controversy remains regarding indications for its use. Neither large-scale nor long-term studies have been initiated, in part because of theoretical concern regarding the risks associated with testosterone therapy, especially the possible stimulation of prostate cancer. This article discusses what is known (and not known) about the risks of testosterone-replacement therapy and provides recommendations for monitoring men who are receiving testosterone.

Integrity signals

Registry

Crossref · 10.1056/nejmra022251

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
STUDIES ON PROSTATIC CANCER
Huggins, C. (1941) · Archives of Surgery · doi:10.1001/archsurg.1941.01210140043004 · Cited by 1,694
Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA · doi:10.1001/jama.1992.03480160073037 · Cited by 1,076
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R., Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., & Ross, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3988 · Cited by 920
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients
Sakr, W., Haas, G. P., Cassin, B. F., Pontes, J. E., & Crissman, J. D. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35487-3 · Cited by 744
Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
Huggins, C., & Hodges, C. (2002) · Journal of Urology · doi:10.1016/s0022-5347(02)80307-x · Cited by 637

Show all 77 references

Research works printed but not linked: 11

10.1210/jc.86.2.724 · DOI · Paper page
10.1210/jc.82.6.1661 · DOI
10.1210/jc.83.10.3443 · DOI
10.1210/jc.82.11.3793 · DOI
10.1210/jc.87.1.136 · DOI
10.1210/jc.87.4.1467 · DOI
Barrett-Connor EL, 1995, Diabetes Metab, 21, 156
2002, Endocr Rep, 2, 1
10.1210/jc.86.6.2380 · DOI
Westaby D, 1977, Lancet, 2, 262
10.1345/aph.1A020 · DOI · Paper page

Sorted by citations

Items 101–200 of 713

Male hypogonadism. Part I: Epidemiology of hypogonadism
Seftel, A. D. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901397 · Cited by 76
Testosterone Therapy in Men With Prostate Cancer: Scientific and Ethical Considerations
Morgentaler, A. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.11.028 · Cited by 78
Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes
Ory, J., Flannigan, R. K., Lundeen, C. J., Huang, J. G., Pommerville, P. J., & Goldenberg, S. L. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.04.069 · Cited by 78
Hormonal therapy for prostate cancer.
Brawer, M. K. (2006) · Europe PMC (PubMed Central) · Cited by 76
Not so benign haematology: anaemia of the elderly
Merchant, A. A., & Roy, C. N. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08920.x · Cited by 78
Testosterone Levels Among Men with Spinal Cord Injury
Clark, M. J., Schopp, L. H., Mazurek, M. O., Zaniletti, I., Lammy, A. B., Martin, T., Thomas, F. P., & Acuff, M. E. (2008) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3181837f4f · Cited by 76
Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male
Jones, S. D., Dukovac, T., Sangkum, P., Yafi, F. A., & Hellstrom, W. J. G. (2015) · Sexual Medicine Reviews · doi:10.1002/smrj.43 · Cited by 76
Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome
Jones, T. H. (2007) · European Urology Supplements · doi:10.1016/j.eursup.2007.07.002 · Cited by 76
Sexual health in hematopoietic stem cell transplant recipients
Li, Z., Mewawalla, P., Stratton, P., Yong, A. S. M., Shaw, B. E., Hashmi, S. K., Jagasia, M., Mohty, M., Majhail, N. S., Savani, B. N., et al. (2015) · Cancer · doi:10.1002/cncr.29675 · Cited by 75
Androgen Action in Prostate Cancer
Basu, S., & Tindall, D. J. (2010) · Hormones and Cancer · doi:10.1007/s12672-010-0044-4 · Cited by 78
The practical management of testosterone deficiency in men
Aversa, A., & Morgentaler, A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.238 · Cited by 75
Are declining testosterone levels a major risk factor for ill-health in aging men?
Yeap, B. B. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.60 · Cited by 75
Clinical Practice Manual for Late‐onset Hypogonadism Syndrome
Namiki, M., Akaza, H., Shimazui, T., Ito, N., Iwamoto, T., Baba, K., Kumano, H., Koh, E., Tsujimura, A., Matsumiya, K., et al. (2008) · International Journal of Urology · doi:10.1111/j.1442-2042.2008.02010.x · Cited by 71
Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen
Pastuszak, A. W., Gomez, L. P., Scovell, J. M., Khera, M., Lamb, D. J., & Lipshultz, L. I. (2015) · Sexual Medicine · doi:10.1002/sm2.76 · Cited by 71
Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men
Kaufman, J. M., Miller, M. G., Garwin, J. L., Fitzpatrick, S., McWhirter, C., & Brennan, J. J. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02265.x · Cited by 70
Prostate‐specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy
Coward, R. M., Simhan, J., & Carson III, C. C. (2009) · BJU International · doi:10.1111/j.1464-410x.2008.08240.x · Cited by 70
Testosterone Supplementation does not Worsen Lower Urinary Tract Symptoms
Pearl, J. A., Berhanu, D., François, N., Masson, P., Zargaroff, S., Cashy, J., & McVary, K. T. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.05.111 · Cited by 70
The role of testosterone in the pathogenesis of prostate cancer
Imamoto, T., Suzuki, H., Yano, M., Kawamura, K., Kamiya, N., Araki, K., Komiya, A., Nihei, N., Naya, Y., & Ichikawa, T. (2008) · International Journal of Urology · doi:10.1111/j.1442-2042.2008.02074.x · Cited by 72
Prostate cancer risk in testosterone-treated men
Raynaud, J. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.032 · Cited by 70
Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms.
Du, X.-J., Fang, L., & Kiriazis, H. (2006) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2005.10.016 · Cited by 75
Prevention of Hormone-Related Cancers: Breast Cancer
Dunn, B. K., Wickerham, D. L., & Ford, L. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.028 · Cited by 69
The association of time of day and serum testosterone concentration in a large screening population
Crawford, E. D., Barqawi, A. B., O’Donnell, C., & Morgentaler, A. (2007) · BJU International · doi:10.1111/j.1464-410x.2007.07022.x · Cited by 68
Self-citation
Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone
Wiehle, R. D., Fontenot, G. K., Wike, J., Hsu, K., Nydell, J., & Lipshultz, L. I. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.06.004 · Cited by 68
Analytical and physiological factors affecting the interpretation of serum testosterone concentration in men
Diver, M. J. (2005) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456306775141803 · Cited by 70
Testosterone treatment increases thromboxane function in rat cerebral arteries
Gonzales, R. J., Ghaffari, A. A., DUCKLES, S. P., & Krause, D. N. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00958.2004 · Cited by 68
Low testosterone levels and decline in physical performance and muscle strength in older men: findings from two prospective cohort studies
Schaap, L. S., Pluijm, S. M. F., Deeg, D. J. H., Penninx, B. W. J. H., Nicklas, B. J., Lips, P. T. A. M., Harris, T. B., Newman, A. B., Kritchevsky, S., Cauley, J. A., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02997.x · Cited by 66
Gender Differences in Cardiac Hypertrophy
Wu, J., Dai, F., Li, C., & Zou, Y. (2019) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-019-09907-z · Cited by 66
Tissue selectivity and potential clinical applications of trenbolone (17β-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity
Yarrow, J. F., McCoy, S. C., & Borst, S. E. (2010) · Steroids · doi:10.1016/j.steroids.2010.01.019 · Cited by 69
Testosterone replacement in prostate cancer survivors with hypogonadal symptoms
Leibowitz, R. L., Dorff, T. B., Tucker, S. J., Symanowski, J. T., & Vogelzang, N. J. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08980.x · Cited by 65
Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine
Morgentaler, A., Traish, A. M., Hackett, G. I., Jones, T. H., & Ramasamy, R. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2019.06.003 · Cited by 67
Prostate Tissue Androgens: History and Current Clinical Relevance
Marks, L. S., Mostaghel, E. A., & Nelson, P. S. (2008) · Urology · doi:10.1016/j.urology.2008.03.033 · Cited by 64
Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Lunenfeld, B., Mskhalaya, G. J., Zitzmann, M., Corona, G., Arver, S., Kalinchenko, S. Y., Tishova, Y. A., & Morgentaler, A. (2021) · The Aging Male · doi:10.1080/13685538.2021.1962840 · Cited by 65
Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats
Razmara, A., Krause, D. N., & DUCKLES, S. P. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00465.2005 · Cited by 62
Screening and Monitoring in Men Prescribed Testosterone Therapy in the U.S., 2001–2010
Baillargeon, J., Urban, R. J., Kuo, Y.-F., Holmes, H. M., Raji, M. A., Morgentaler, A., Howrey, B. T., Lin, Y.-L., & Ottenbacher, K. J. (2015) · Public Health Reports® · doi:10.1177/003335491513000207 · Cited by 61
Low testosterone and anaemia in men with type 2 diabetes
Grossmann, M., Panagiotopolous, S., Sharpe, K., MacIsaac, R. J., Clarke, S., Zajac, J. D., Jerums, G., & Thomas, M. C. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03357.x · Cited by 60
Testosterone replacement therapy for male hypogonadism: Part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents
Seftel, A. D. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901366 · Cited by 60
Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets
Ip, F. F., di Pierro, I., Brown, R., Cunningham, I., Handelsman, D. J., & Liu, P. Y. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0717 · Cited by 59
Testosterone treatment in the aging male: myth or reality?
Nigro, N., & Christ‐Crain, M. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13539 · Cited by 59
Evidence-based approach to cutaneous hyperandrogenism in women
Schmidt, T. H., & Shinkai, K. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.026 · Cited by 60
Male hypogonadism: pathogenesis, diagnosis, and management
de Silva, N. L., Papanikolaou, N., Grossmann, M., Antonio, L., Quinton, R., Anawalt, B. D., & Jayasena, C. N. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00199-2 · Cited by 68
Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research
Gooren, L. J., Behre, H. M., Saad, F., Frank, A., & Schwerdt, S. (2007) · The Aging Male · doi:10.1080/13685530701600885 · Cited by 59
Male Hypogonadism
Darby, E. L., & Anawalt, B. D. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504050-00003 · Cited by 60
Long-term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer
Baillargeon, J., Kuo, Y., Fang, X., & Shahinian, V. B. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.05.099 · Cited by 58
Diagnosis and Treatment of Hypopituitarism: An Update
van Aken, M. V., & Lamberts, S. (2005) · Pituitary · doi:10.1007/s11102-006-6039-z · Cited by 60
Respiratory and Skeletal Muscles in Hypogonadal Men with Chronic Obstructive Pulmonary Disease
Laghi, F., Langbein, W. E., Antonescu-Turcu, A., Jubran, A., Bammert, C., & Tobin, M. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1643oc · Cited by 57
Testosterone treatments: why, when, and how?
Margo, K. L., & Winn, R. (2006) · PubMed · Cited by 56
Discovery of Potent and Muscle Selective Androgen Receptor Modulators through Scaffold Modifications
Li, J. J., Sutton, J. C., Nirschl, A. A., Zou, Y., Wang, H., Sun, C., Pi, Z., Johnson, R., Stanley R. Krystek, Seethala, R., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070312d · Cited by 58
PROSTATE CANCER IN MEN USING TESTOSTERONE SUPPLEMENTATION
Gaylis, F. D., Lin, D. W., Ignatoff, J. M., Amling, C. L., Tutrone, R. F., Jr., & Cosgrove, D. J. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000165166.36280.60 · Cited by 56
Discovery of Potent, Orally-Active, and Muscle-Selective Androgen Receptor Modulators Based on an N-Aryl-hydroxybicyclohydantoin Scaffold
Sun, C., Robl, J. A., Wang, T. C., Huang, Y., Kuhns, J. E., Lupisella, J. A., Beehler, B. C., Golla, R., Sleph, P. G., Seethala, R., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm061101w · Cited by 56
The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS)
Khera, M., Bhattacharya, R. K., Blick, G., Kushner, H., Nguyen, D., & Miner, M. M. (2011) · The Aging Male · doi:10.3109/13685538.2011.606513 · Cited by 56
Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon‐α therapy
Nguyen, H. V., Mollison, L. C., Taylor, T., Chubb, S. A. P., & Yeap, B. B. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01093.x · Cited by 55
Double‐blind placebo‐controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism
Merza, Z., Blumsohn, A., Mah, P., Meads, D. M., McKenna, S. P., Wylie, K. R., Eastell, R., Wu, F. C. W., & Ross, R. J. M. (2005) · International Journal of Andrology · doi:10.1111/j.1365-2605.2005.00612.x · Cited by 54
Wide Variability in Laboratory Reference Values for Serum Testosterone
Lazarou, S., Reyes-Vallejo, L., & Morgentaler, A. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00334.x · Cited by 83
Identification of a 4-(Hydroxymethyl)diarylhydantoin as a Selective Androgen Receptor Modulator
Nique, F., Hebbe, S., Triballeau, N., Peixoto, C., Lefrançois, J.-M., Jary, H., Alvey, L. J., Manioc, M., Housseman, C., Klaassen, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300281x · Cited by 54
Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy
Rhoden, E. L., & Morgentaler, A. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901394 · Cited by 52
Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study
Yeap, B. B., Almeida, O. P., Hyde, Z., Norman, P. E., Chubb, S. A. P., Jamrozik, K. D., Hankey, G. J., & Flicker, L. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03372.x · Cited by 53
Testosterone Levels Among Men with Spinal Cord Injury Admitted to Inpatient Rehabilitation
Schopp, L. H., Clark, M., Mazurek, M. O., Hagglund, K. J., Acuff, M. E., Sherman, A., & Childers, M. K. (2006) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000228617.94079.4a · Cited by 53
Efficacy and safety of long‐acting intramuscular testosterone undecanoate in aging men: a randomised controlled study
Tan, W. S., Low, W. Y., Ng, C. J., Tan, W. K., Tong, S. F., Ho, C. C. K., Khoo, E. M., Lee, G., Lee, B. C., Lee, V., et al. (2013) · British Journal of Urology · doi:10.1111/bju.12037 · Cited by 51
Testosterone Replacement Therapy for Older Men
Wald, M., Meacham, R. B., Ross, L. S., & NIEDERBERGER, C. S. (2006) · Journal of Andrology · doi:10.2164/jandrol.05036 · Cited by 52
Prevalence of low testosterone and its relationship to body mass index in older men with lower urinary tract symptoms associated with benign prostatic hyperplasia
Kaplan, S. A., Lee, J. Y., O’Neill, E. A., Meehan, A. G., & Kusek, J. W. (2013) · The Aging Male · doi:10.3109/13685538.2013.844786 · Cited by 51
Testosterone Measurement in Patients with Prostate Cancer
Schulman, C. C., Irani, J., Moróte, J., Schalken, J. A., Montorsi, F., Chłosta, P. L., & Heidenreich, A. (2010) · European Urology · doi:10.1016/j.eururo.2010.04.001 · Cited by 51
Effect of Isopropyl Myristate on Transdermal Permeation of Testosterone From Carbopol Gel
Zidan, A. S., Kamal, N. S., Alayoubi, A. Y., Seggel, M. R., Ibrahim, S. A., Rahman, Z., Cruz, C. N., & Ashraf, M. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.03.016 · Cited by 52
The Evolutionary Psychology of Human Mate Choice
Sefcek, J. A., Brumbach, B. H., Vásquez, G., & Miller, G. F. (2007) · Journal of Psychology & Human Sexuality · doi:10.1300/j056v18n02_05 · Cited by 56
Glucocorticoid-induced osteoporosis
Silverman, S. L., & Lane, N. E. (2009) · Current Osteoporosis Reports · doi:10.1007/s11914-009-0005-4 · Cited by 50
Predicting Biochemical Response to Clomiphene Citrate in Men with Hypogonadism
Mazzola, C. R., Katz, D. J., Loghmanieh, N., Nelson, C. J., & Mulhall, J. P. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12592 · Cited by 50
Pattern of Endocrinal Changes in Patients with Sexual Dysfunction
El‐Sakka, A. I., Hassoba, H. M., Sayed, H. M., & Tayeb, K. A. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.00082.x · Cited by 50
Testosterone action on erythropoiesis does not require its aromatization to estrogen: Insights from the testosterone and estrogen treatment of two aromatase-deficient men
Rochira, V., Zirilli, L., Madeo, B., MAFFEI, L. E., & Carani, C. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.007 · Cited by 50
Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors
Jostel, A., Mukherjee, A., Hulse, P. A., & Shalet, S. M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02282.x · Cited by 50
Testosterone, cardiomyopathies, and heart failure
Diaconu, R., Donoiu, I., Mirea, O., & Bălşeanu, T. A. (2021) · Asian Journal of Andrology · doi:10.4103/aja.aja_80_20 · Cited by 51
Glucocorticoid-Induced Osteoporosis: From Basic Mechanisms to Clinical Aspects
Alesci, S., Martino, M. U. D., Ilias, Ι., Gold, P. W., & Chrousos, G. P. (2005) · NeuroImmunoModulation · doi:10.1159/000082360 · Cited by 48
Vitamin D is significantly associated with total testosterone and sex hormone-binding globulin in Malaysian men
Chin, K., Ima-Nirwana, S., & Ngah, W. Z. W. (2015) · The Aging Male · doi:10.3109/13685538.2015.1034686 · Cited by 50
Hypogonadotropic Hypogonadism in Men with Type 2 Diabetes
Dandona, P., Dhindsa, S., Chandel, A., & Chaudhuri, A. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.05.2001 · Cited by 47
A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study
Wheeler, K. M., Smith, R. P., Kumar, R. A., Setia, S., Costabile, R. A., & Kavoussi, P. K. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.068 · Cited by 47
Transgender Health Concerns
Lawrence, A. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-31334-4_19 · Cited by 47
Testosterone Therapy in Men With Prostate Cancer: Scientific and Ethical Considerations
Morgentaler, A. (2009) · The Journal of Urology · doi:10.1016/j.juro.2008.11.031 · Cited by 47
Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance
Francisco, I. F. S., Rojas, P. A., DeWolf, W. C., & Morgentaler, A. (2014) · British Journal of Urology · doi:10.1111/bju.12682 · Cited by 46
Synthesis, Structure−Activity Relationships, and Characterization of Novel Nonsteroidal and Selective Androgen Receptor Modulators
Schlienger, N., Lund, B. W., Pawlas, J., Badalassi, F., Bertozzi, F., Lewinsky, R., Fejzic, A., Thygesen, M. B., Tabatabaei, A., Bradley, S. R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901149c · Cited by 46
Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment
Ribeiro, R. S., & Abucham, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0084 · Cited by 47
Testosterone replacement therapy for older men
Borst, S. E. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1609 · Cited by 46
“Rhoden and Morgentaler (2004) have reviewed the adverse effects and recommend the following monitoring.”
The Ratio of Serum Testosterone-to-Prostate Specific Antigen Predicts Prostate Cancer in Hypogonadal Men
Rhoden, E. L., Riedner, C. E., & Morgentaler, A. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.01.045 · Cited by 45
The History of Testosterone and the Evolution of its Therapeutic Potential
Morgentaler, A., & Traish, A. M. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.03.002 · Cited by 45
The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness
Moróte, J., Ramirez, C., Gómez, E. J., Planas, J., Raventos, C. X., de Torres, I. M., & Catalán, R. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08378.x · Cited by 44
Pharmacokinetic Evaluation and Dosing of Subcutaneous Testosterone Pellets
Pastuszak, A. W., Mittakanti, H. R., Liu, J. S., Gomez, L., Lipshultz, L. I., & Khera, M. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.016295 · Cited by 44
Differences in the Apparent Metabolic Clearance Rate of Testosterone in Young and Older Men with Gonadotropin Suppression Receiving Graded Doses of Testosterone
Coviello, A. D., Lakshman, K. M., Mazer, N. A., & Bhasin, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0822 · Cited by 44
Testosterone replacement therapy for late-onset hypogonadism
Cunningham, G. R. (2006) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0479 · Cited by 44
Update on Glucocorticoid-Induced Osteoporosis
Maricic, M. J. (2011) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2011.07.003 · Cited by 45
Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes
Kaplan, A. L., & Hu, J. C. (2013) · Urology · doi:10.1016/j.urology.2013.03.049 · Cited by 42
The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease
Williams, G. P. (2010) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328338f7d2 · Cited by 42
Opioid-Induced Androgen Deficiency (OPIAD): Diagnosis, Management, and Literature Review
O’Rourke, T. K., & Wosnitzer, M. S. (2016) · Current Urology Reports · doi:10.1007/s11934-016-0634-y · Cited by 43
Partial androgen deficiency, depression and testosterone treatment in aging men
Amore, M., Scarlatti, F., Quarta, A. L., & Tagariello, P. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324891 · Cited by 41
Low Testosterone and the Association With Type 2 Diabetes
Farrell, J. A. B., Deshmukh, A., & Baghaie, A. A. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708323100 · Cited by 39
Risks of testosterone replacement therapy in ageing men
TAN, R. S.-H., & Salazar, J. A. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.6.599 · Cited by 41
Potential application of testosterone replacement therapy as treatment for obesity and type 2 diabetes in men
Fink, J. E., Matsumoto, M., & Tamura, Y. (2018) · Steroids · doi:10.1016/j.steroids.2018.08.002 · Cited by 42
Hypertensive Cardiac Remodeling in Males and Females
Deschepper, C. F., & Llamas, B. (2007) · Hypertension · doi:10.1161/01.hyp.0000256279.49882.d8 · Cited by 40
Acne in Adolescence and Cause-specific Mortality: Lower Coronary Heart Disease but Higher Prostate Cancer Mortality
Galobardes, B., Smith, G. D., Jeffreys, M., Kinra, S., & McCarron, P. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi147 · Cited by 38
Topical Testosterone Supplementation for the Treatment of Male Hypogonadism
Abadilla, K., & Dobs, A. S. (2012) · Drugs · doi:10.2165/11635620-000000000-00000 · Cited by 38
Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
Miner, M. M., & Seftel, A. D. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01317.x · Cited by 37
Epidemiology and pathophysiology of male sexual dysfunction
Kaminetsky, J. C. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.16 · Cited by 39
Substituted 6-(1-Pyrrolidine)quinolin-2(1H)-ones as Novel Selective Androgen Receptor Modulators
Martinborough, E., Shen, Y., van Oeveren, A., Long, Y. O., Lau, T. L. S., Marschke, K. B., Chang, W. Y., LÓPEZ, F. J., Vajda, E. G., Rix, P. J., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070231h · Cited by 38
Two Years of Testosterone Therapy Associated with Decline in Prostate-Specific Antigen in a Man with Untreated Prostate Cancer
Morgentaler, A. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01066.x · Cited by 38

Authors: Rhoden, E. L., & Morgentaler, A.
Affiliations: Beth Israel Deaconess Medical Center (US)
ORCID: Morgentaler, Abraham
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2004-01-29
Volume: 350
Issue: 5
Pages: 482-492
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra022251
OpenAlex: W2120158027
Cited by: 705
References: 77
Citations by year: 2026: 5 · 2025: 7 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 16 · 2020: 18 · 2019: 21 · 2018: 19 · 2017: 20 · 2016: 22 · 2015: 36 · 2014: 30 · 2013: 35 · 2012: 44
FWCI: 9.78
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords: testosterone replacement therapy, risk, prostate cancer, older men, monitoring, androgen therapy, hypogonadism
MeSH terms: Cardiovascular Diseases, Humans, Hypogonadism, Lipids, Male, Polycythemia, Prostatic Diseases, Risk Factors, Testosterone, Drug Monitoring, Prostate-Specific Antigen, Age Distribution, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risks of testosterone-replacement therapy and recommendations for monitoring.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks